RSS

review

The European Medicines Agency (EMA) has accepted for review an application for an add-on maintenance treatment in certain adults and adolescents (12 years and older) with inadequately controlled moderate-to-severe asthma, Dupixent (dupilumab). more

News

A systematic review and network meta-analysis, published in The Lancet, evaluating 21 antidepressants has proven the efficacy of treatment versus placebo in adults with major depressive disorder. more

News

NHS England’s funded programme, Small Business Research Initiative (SBRI) Healthcare, has been recognised as ‘the best role model’ in an independent review by David Connell. more

News

Helsinn’s anamorelin HCI has been accepted for marketing authorisation application (MAA) review by the European Medicines Agency (EMA) more

News